Researchers create an atlas of health associations for GLP-1 receptor agonists

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for gastrointestinal and musculoskeletal issues.

Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab – Pharmaceutical Technology

Biopharmaceuticals company AbbVie have pulled out of their deal with I-Mab. Photo: Valeriya Zankovych / Shutterstock.com. Biopharma giant AbbVie has announced it intends to terminate

September 25, 2023

Opinion | ‘It Is a Horrifying Prospect’: What We Heard This Year

In place of our usual “What We Heard This Week” feature, and as part of our year-end wrap-ups, we’ve selected some of the best quotes

January 1, 2024

UNIGE’s synthetic anticoagulant provides reliable alternative to heparin

Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis.

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.